Decision

Apotex Inc. v. Eli Lilly Canada Inc., 2009 FC 693 (Raloxifene*)

Proth. Tabib - 2009-07-03

Read full decision. Automatically generated summary:

The present motion is brought in the context of an action taken by Apotex Inc. ("Apotex") against Eli Lilly Canada Inc. ("Lilly"), for damages pursuant to section 8 of the Patented Medicines (Notice of Compliance ) Regulations (the "Regulations"). Lilly seeks an Order pursuant to Rule 221 of the Federal Courts Rules striking out paragraphs 1(b) and 22 to 28 of Apotex' statement of claim, in which Apotex seeks disgorgement of Lilly's revenues in application of the principles of unjust enrichment.

Decision relates to:

  • T-656-09 - APOTEX INC. v. ELI LILLY CANADA INC.

 

Canadian Intellectual Property